HLA-B*07:02 protein (SBP Tag)
-
- Target
- HLA-B*07:02
- Protein-Typ
- Recombinant
- Spezies
- Human
- Quelle
- Mammalian Cells
- Aufreinigungstag / Konjugat
- SBP Tag
- Applikation
- Blocking Peptide (BP), Control Peptide (CP), ELISA, Neutralization (Neut)
- Verwendungszweck
- The product is HLA-B*07:02 complexed with β2-microglobulin (b2m)
- Sequenz
-
heavy chain: GSHSMRYFYT SVSRPGRGEP RFISVGYVDD TQFVRFDSDA ASPREEPRAP WIEQEGPEYW DRNTQIYKAQ AQTDRESLRN LRGYYNQSEA GSHTLQSMYG CDVGPDGRLL RGHDQYAYDG KDYIALNEDL RSWTAADTAA QITQRKWEAA REAEQRRAYL EGECVEWLRR YLENGKDKLE RADPPKTHVT HHPISDHEAT LRCWALGFYP AEITLTWQRD GEDQTQDTEL VETRPAGDRT FQKWAAVVVP SGEEQRYTCH VQHEGLPKPL TLRWEPSSQS TVPI
light chain: IQRTPKIQVY SRHPAENGKS NFLNCYVSGF HPSDIEVDLL KNGERIEKVE HSDLSFSKDW SFYLLYYTEF TPTEKDEYAC RVNHVTLSQP KIVKWDRDM
Sequences without tags. Tag location is at the discretion of the manufacturer. - Spezifität
-
HLA-B*07:02 complexed with b2m, P01889 / P61769
HLA-B*07:02 presents peptides with the common motif of a proline residue at position 2 and a leucine residue at the c-terminal position 9, e.g. self-peptides derived from signal sequences or viral peptides derived from HIV or SARS-CoV-2. - Produktmerkmale
- HLAs are produced in mammalian cell cultures as recombinant, truncated, soluble antigens, in complex with β2-microglobulin (HLA class I). As part of our quality control, all HLA are analyzed for purity by gel electrophoresis, concentration is determined by ELISA (0.5 mg/ml) and their functionality is verified with a specific antiserum.
- Aufreinigung
- Chromatography
- Reinheit
- > 80 %
- Endotoxin-Niveau
- Endotoxins have not been removed
-
- Applikationshinweise
- ELISA: 1 - 100 ng/mL
- Kommentare
-
sandwich ELISA, direct ELISA, bead ELISA, reactive with antibodies W6/32 and BBM.1 and specific antiserum, B cell ELI Spot (predicted), in vitro memory B cell stimulation (predicted), HLA competition assay (predicted), control in various assays (predicted)
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- TRIS based buffer, pH 8.0, Sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 6 months
-
- Target
- HLA-B*07:02
- Hintergrund
- Human Leukozyte Antigen, human Antigen-presenting major histocompatibility complex class I (MHCI) molecule. Expressed on all cells, displays peptides to CD8-positive T cells. Involved in cellular immune response.
- Molekulargewicht
- approx. 50 kDa (38 kDa heavy chain + 12 kDa b2m)
- UniProt
- P01889
-